World Orphan Drug Congress Europe

The World Orphan Drug Congress Europe 2026 is the leading global event for orphan drugs and rare diseases, bringing together pharmaceutical and biotech leaders, regulators, researchers, investors, healthcare professionals, and patient advocacy groups. Held in Amsterdam from 26–28 October 2026, the congress covers the entire rare disease ecosystem, including cell and gene therapy, genetic testing, market access, pricing and reimbursement, real-world evidence, clinical trials, and orphan drug policy. With more than 1,800 attendees, 250+ expert speakers, extensive one-to-one partnering meetings, and dedicated networking opportunities, the event provides a unique platform to discover emerging therapies, gain actionable industry insights, build strategic partnerships, and help shape the future of rare disease innovation and patient access worldwide.